Correction to: Survival from breast cancer in women with a BRCA2 mutation by treatment

Affiliations

• ¹ Genomic Medicine, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK.
• ² Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia.
• ³ Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia.
• ⁴ Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC, Australia.
• ⁵ Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia.
• ⁶ Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, VIC, Australia.
• ⁷ Department of Medicine and Surgery, University of Milan-Bicocca, Milan, Italy.
• ⁸ Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland.
• ⁹ University of Zielona Góra, Zielona Góra, Poland.
• ¹⁰ Women's College Research Institute, Women's College Hospital, Toronto, ON, Canada.
• ¹¹ Division of Human Genetics, the Ohio State University Medical Center, Comprehensive Cancer Center, Columbus, OH, USA.
• ¹² Division of Clinical Cancer Genomics, Department of Population Sciences, City of Hope, Duarte, CA, USA.
• ¹³ Beth Israel Deaconess Medical Center, Boston, MA, USA.
• ¹⁴ Nancy and James Grosfeld Cancer Genetics Center, Beaumont Cancer Institute, Beaumont Health, Royal Oak, MI, USA.
• ¹⁵ Manchester Academic Health Science Centre, Department of Medical Oncology, The Christie, Manchester, UK.
• ¹⁶ Women's College Research Institute, Women's College Hospital, Toronto, ON, Canada. steven.narod@wchospital.ca.